Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Europe Muscular Dystrophy Market Pipeline and Competitive Landscape Report 2016 - Research and Markets

Research and Markets
Posted on: 24 Oct 16

Research and Markets has announced the addition of the "Europe Muscular Dystrophy Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

Europe Muscular Dystrophy Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Muscular Dystrophy pipeline products, Muscular Dystrophy epidemiology, Muscular Dystrophy market valuations and forecast, Muscular Dystrophy products sales and competitive landscape.

This report is classified into nine sections - Muscular Dystrophy overview including etiology, pathophysiology, and diagnosis, Muscular Dystrophy treatment options, Muscular Dystrophy pipeline products, Muscular Dystrophy market analysis in Europe and by each country.

The market analysis comprises of Muscular Dystrophy epidemiology, key products marketed for Muscular Dystrophy, market valuations and forecast, products sales and market shares.

Research Scope:

  • Pipeline: Find out the products in clinical trials for the treatment of Muscular Dystrophy by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Epidemiology: Find out the number of patients diagnosed (prevalence) with Muscular Dystrophy
  • Products: Identify key products marketed and prescribed for Muscular Dystrophy including trade name, molecule name, and company
  • Product Sales: Find out the sales revenues of Muscular Dystrophy products, both branded and generics
  • Market Valuations: Find out the market size for Muscular Dystrophy products in 2015 for the markets: Find out how the market advanced from 2010 and forecast to 2020
  • Products Market Share: Find out the market shares for key Muscular Dystrophy products

Key Topics Covered:

1 Disease Overview

2 Muscular Dystrophy Treatments

3 Muscular Dystrophy Pipeline

4 Europe Muscular Dystrophy Market Insights

5 Germany Muscular Dystrophy Market Insights

6 France Muscular Dystrophy Market Insights

7 Italy Muscular Dystrophy Market Insights

8 Spain Muscular Dystrophy Market Insights

9 UK Muscular Dystrophy Market Insights

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 24/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.